Literature DB >> 2564527

Treatment of refractory ulcerative colitis with cyclosporin enemas.

J Brynskov, L Freund, O O Thomsen, C B Andersen, S N Rasmussen, V Binder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2564527     DOI： 10.1016/s0140-6736(89)92232-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

2.  The absorption site of cyclosporin in the human gastrointestinal tract.

Authors:  J Drewe; C Beglinger; T Kissel
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin.

Authors:  S N Murthy; H S Cooper; H Shim; R S Shah; S A Ibrahim; D J Sedergran
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

5.  Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin.

Authors:  W J Sandborn; R H Wiesner; W J Tremaine; N F Larusso
Journal:  Gut       Date:  1993-02       Impact factor: 23.059
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.